Frontiers in CAR-T cell therapy for autoimmune diseases
Trends in Pharmacological Sciences · 2024-09 · 45 (9) · 839-857
DOI: 10.1016/j.tips.2024.07.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2024-09. Verfasst von Yan-Ruide Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: c…. Hauptthemen laut MEDLINE: Autoimmune Diseases, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy has demonstrated significant success in treating cancers. The potential of CAR-T cells is now being explored in the context of autoimmune diseases. Recent clinical trials have shown sustained and profound elimination of autoreactive B cells by CAR-T cells, leading to promising autoimmune disease control with minimal safety concerns. These encouraging results have inspired further investigation into CAR-T cell applications for a broader range of autoimmune diseases and the development of advanced cell products with improved efficacy and safety. In this review, we discuss the mechanisms by which CAR-T cells target autoimmune conditions, summarize current preclinical models, and highlight ongoing clinical trials, including CAR-T therapy design, clinical outcomes, and challenges. Additionally, we discuss the limitations and future directions of CAR-T therapy in the treatment of autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: charlie.li@ucla.edu.
- Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
- Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA 90095,…
Zitieren
APA
Li, Y. R., Lyu, Z., Chen, Y., Fang, Y., & Yang, L. (2024). Frontiers in CAR-T cell therapy for autoimmune diseases. Trends in Pharmacological Sciences, 45(9), 839-857. https://doi.org/10.1016/j.tips.2024.07.005
Vancouver
Li YR, Lyu Z, Chen Y, Fang Y, Yang L. Frontiers in CAR-T cell therapy for autoimmune diseases. Trends in Pharmacological Sciences. 2024;45(9):839-857. doi:10.1016/j.tips.2024.07.005
BibTeX
@article{Li2024,
author = {Li, Yan-Ruide and Lyu, Zibai and Chen, Yuning and Fang, Ying and Yang, Lili},
title = {Frontiers in CAR-T cell therapy for autoimmune diseases},
journal = {Trends in Pharmacological Sciences},
year = {2024},
volume = {45},
number = {9},
pages = {839--857},
doi = {10.1016/j.tips.2024.07.005}
}
EUVIMED